Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Nicholas D. Walter, Camille M. Moore, Xavier A. Kayigire, Christian Dide-Agossou, William Worodria, Laurence Huang, Charles K. Everett, Gary S. Schoolnik, Payam Nahid, J. Lucian Davis

ABSTRACT

BACKGROUND: According to the traditional tuberculosis (TB) treatment paradigm, the initial doses of treatment rapidly kill most Mycobacterium tuberculosis (Mtb) bacilli in sputum, yet many more months of daily treatment are required to eliminate a small, residual subpopulation of drug-tolerant bacilli. This paradigm has recently been challenged following the discovery that up to 90% of Mtb bacilli in sputum are culturable only with growth-factor supplementation. These "differentially culturable" bacilli are hypothesized to be more drug-tolerant than routinely culturable bacilli. This hypothesis implies an alternative paradigm in which TB treatment does not rapidly reduce the total Mtb population but only the small, routinely culturable subpopulation. To evaluate these competing paradigms, we developed a culture-independent method for quantifying the viable fraction of Mtb bacilli in sputum during treatment. METHODS: We used GeneXpert MTB/RIF to quantify Mtb DNA in sputa collected longitudinally from Ugandan adults taking standard 4-drug treatment for drug-susceptible pulmonary TB. We modeled GeneXpert cycle thresholds over time using nonlinear mixed-effects regression. We adjusted these models for clearance of DNA from killed-but-not-yet-degraded bacilli, assuming clearance half-lives ranging from 0 to 1.25 days. We used a convolution integral to quantify DNA from viable bacilli only, and converted cycle thresholds to Mtb genomic equivalents. We replicated our results in a South African cohort. RESULTS: We enrolled 41 TB patients in Uganda. Assuming a DNA-clearance half-life of 0 days, genomic equivalents of viable sputum bacilli decreased by 0.22 log/day until 8.8 days, then by 0.07 log/day afterwards. Assuming a DNA-clearance half-life of 1.25 days, genomic equivalents of viable bacilli decreased by 0.36 log/day until 5.0 days, then by 0.06 log/day afterwards. By day 7, viable Mtb had decreased by 97.2-98.8%. We found similar results for 19 TB patients in South Africa. DISCUSSION: Using a culture-independent method, we found that TB treatment rapidly eliminates most viable Mtb in sputum. These findings are incompatible with the hypothesis that differentially culturable bacilli are drug-tolerant. CONCLUSIONS: A culture-independent method for measuring viable Mtb in sputum during treatment corroborates the traditional TB treatment paradigm in which a rapid bactericidal phase precedes slow, elimination of a small, residual bacillary subpopulation. More... »

PAGES

293

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12879-018-3213-7

DOI

http://dx.doi.org/10.1186/s12879-018-3213-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1105294105

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29970012


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Colorado Anschutz Medical Campus", 
          "id": "https://www.grid.ac/institutes/grid.430503.1", 
          "name": [
            "Pulmonary Section, Denver VA Medical Center, Denver, CO, USA", 
            "Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Walter", 
        "givenName": "Nicholas D.", 
        "id": "sg:person.01072660333.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072660333.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Jewish Health", 
          "id": "https://www.grid.ac/institutes/grid.240341.0", 
          "name": [
            "Division of Biostatistics and Bioinformatics, National Jewish Health, Denver, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moore", 
        "givenName": "Camille M.", 
        "id": "sg:person.010043724025.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010043724025.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Colorado Anschutz Medical Campus", 
          "id": "https://www.grid.ac/institutes/grid.430503.1", 
          "name": [
            "Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kayigire", 
        "givenName": "Xavier A.", 
        "id": "sg:person.01130221352.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130221352.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Colorado School of Public Health", 
          "id": "https://www.grid.ac/institutes/grid.414594.9", 
          "name": [
            "Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dide-Agossou", 
        "givenName": "Christian", 
        "id": "sg:person.014310416353.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014310416353.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Infectious Disease Research Collaboration, Kampala, Uganda", 
            "Department of Medicine, Mulago Hospital, Makerere University, Kampala, Uganda"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Worodria", 
        "givenName": "William", 
        "id": "sg:person.01135416527.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135416527.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California, San Francisco", 
          "id": "https://www.grid.ac/institutes/grid.266102.1", 
          "name": [
            "Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA", 
            "HIV, Infectious Diseases, and Global Medicine Division, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huang", 
        "givenName": "Laurence", 
        "id": "sg:person.012465155177.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012465155177.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California, San Francisco", 
          "id": "https://www.grid.ac/institutes/grid.266102.1", 
          "name": [
            "Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA", 
            "Pulmonary Associates, Burlingame, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Everett", 
        "givenName": "Charles K.", 
        "id": "sg:person.0706702615.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706702615.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Stanford University", 
          "id": "https://www.grid.ac/institutes/grid.168010.e", 
          "name": [
            "Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schoolnik", 
        "givenName": "Gary S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California, San Francisco", 
          "id": "https://www.grid.ac/institutes/grid.266102.1", 
          "name": [
            "Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nahid", 
        "givenName": "Payam", 
        "id": "sg:person.0711160455.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711160455.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yale University", 
          "id": "https://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Yale School of Public Health, New Haven, CT, USA", 
            "Division of Pulmonary, Critical Care, and Sleep Medicine Section, Yale School of Medicine, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davis", 
        "givenName": "J. Lucian", 
        "id": "sg:person.010564201417.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010564201417.58"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1128/aac.01380-15", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000191663"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/ajrccm.160.1.9811006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003405776"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/dkt357", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012231163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2958.2002.02779.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017319679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/rccm.201607-1431ed", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023909116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrmicro3076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024379299", 
          "https://doi.org/10.1038/nrmicro3076"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.76.6_supplement.771", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026581588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12916-016-0609-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027451381", 
          "https://doi.org/10.1186/s12916-016-0609-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/rccm.201604-0769oc", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029247559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12879-016-1696-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029636369", 
          "https://doi.org/10.1186/s12879-016-1696-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12879-016-1696-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029636369", 
          "https://doi.org/10.1186/s12879-016-1696-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tube.2016.08.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034869919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pmed.0040120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037046441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/jcm.00128-10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040312811"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/rccm.200210-1125oc", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041796096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tube.2010.03.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041902759"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/jiv149", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042306309"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/dku415", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047592023"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/aac.00774-05", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052810980"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/cid/civ1223", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059467409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083123026", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.1705385114", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085731090"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "BACKGROUND: According to the traditional tuberculosis (TB) treatment paradigm, the initial doses of treatment rapidly kill most Mycobacterium tuberculosis (Mtb) bacilli in sputum, yet many more months of daily treatment are required to eliminate a small, residual subpopulation of drug-tolerant bacilli. This paradigm has recently been challenged following the discovery that up to 90% of Mtb bacilli in sputum are culturable only with growth-factor supplementation. These \"differentially culturable\" bacilli are hypothesized to be more drug-tolerant than routinely culturable bacilli. This hypothesis implies an alternative paradigm in which TB treatment does not rapidly reduce the total Mtb population but only the small, routinely culturable subpopulation. To evaluate these competing paradigms, we developed a culture-independent method for quantifying the viable fraction of Mtb bacilli in sputum during treatment.\nMETHODS: We used GeneXpert MTB/RIF to quantify Mtb DNA in sputa collected longitudinally from Ugandan adults taking standard 4-drug treatment for drug-susceptible pulmonary TB. We modeled GeneXpert cycle thresholds over time using nonlinear mixed-effects regression. We adjusted these models for clearance of DNA from killed-but-not-yet-degraded bacilli, assuming clearance half-lives ranging from 0 to 1.25\u00a0days. We used a convolution integral to quantify DNA from viable bacilli only, and converted cycle thresholds to Mtb genomic equivalents. We replicated our results in a South African cohort.\nRESULTS: We enrolled 41\u00a0TB patients in Uganda. Assuming a DNA-clearance half-life of 0\u00a0days, genomic equivalents of viable sputum bacilli decreased by 0.22 log/day until 8.8\u00a0days, then by 0.07 log/day afterwards. Assuming a DNA-clearance half-life of 1.25\u00a0days, genomic equivalents of viable bacilli decreased by 0.36 log/day until 5.0\u00a0days, then by 0.06 log/day afterwards. By day 7, viable Mtb had decreased by 97.2-98.8%. We found similar results for 19\u00a0TB patients in South Africa.\nDISCUSSION: Using a culture-independent method, we found that TB treatment rapidly eliminates most viable Mtb in sputum. These findings are incompatible with the hypothesis that differentially culturable bacilli are drug-tolerant.\nCONCLUSIONS: A culture-independent method for measuring viable Mtb in sputum during treatment corroborates the traditional TB treatment paradigm in which a rapid bactericidal phase precedes slow, elimination of a small, residual bacillary subpopulation.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12879-018-3213-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.3535187", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.5475983", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.4102552", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2421217", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2418123", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2541757", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1024946", 
        "issn": [
          "1471-2334"
        ], 
        "name": "BMC Infectious Diseases", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "name": "Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum", 
    "pagination": "293", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "69630b2fd4a031d4629e7bd79097f6053a54b71832abaaaa1dfa6c71bb22ba04"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29970012"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968551"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12879-018-3213-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1105294105"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12879-018-3213-7", 
      "https://app.dimensions.ai/details/publication/pub.1105294105"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78944_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12879-018-3213-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12879-018-3213-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12879-018-3213-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12879-018-3213-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12879-018-3213-7'


 

This table displays all metadata directly associated to this object as RDF triples.

229 TRIPLES      21 PREDICATES      50 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12879-018-3213-7 schema:about anzsrc-for:11
2 anzsrc-for:1115
3 schema:author N6a621c4a67db4185a56913d0f8da1867
4 schema:citation sg:pub.10.1038/nrmicro3076
5 sg:pub.10.1186/s12879-016-1696-7
6 sg:pub.10.1186/s12916-016-0609-3
7 https://app.dimensions.ai/details/publication/pub.1083123026
8 https://doi.org/10.1016/j.tube.2010.03.007
9 https://doi.org/10.1016/j.tube.2016.08.006
10 https://doi.org/10.1046/j.1365-2958.2002.02779.x
11 https://doi.org/10.1073/pnas.1705385114
12 https://doi.org/10.1093/cid/civ1223
13 https://doi.org/10.1093/infdis/jiv149
14 https://doi.org/10.1093/jac/dkt357
15 https://doi.org/10.1093/jac/dku415
16 https://doi.org/10.1128/aac.00774-05
17 https://doi.org/10.1128/aac.01380-15
18 https://doi.org/10.1128/jcm.00128-10
19 https://doi.org/10.1164/ajrccm.160.1.9811006
20 https://doi.org/10.1164/rccm.200210-1125oc
21 https://doi.org/10.1164/rccm.201604-0769oc
22 https://doi.org/10.1164/rccm.201607-1431ed
23 https://doi.org/10.1371/journal.pmed.0040120
24 https://doi.org/10.1378/chest.76.6_supplement.771
25 schema:datePublished 2018-12
26 schema:datePublishedReg 2018-12-01
27 schema:description BACKGROUND: According to the traditional tuberculosis (TB) treatment paradigm, the initial doses of treatment rapidly kill most Mycobacterium tuberculosis (Mtb) bacilli in sputum, yet many more months of daily treatment are required to eliminate a small, residual subpopulation of drug-tolerant bacilli. This paradigm has recently been challenged following the discovery that up to 90% of Mtb bacilli in sputum are culturable only with growth-factor supplementation. These "differentially culturable" bacilli are hypothesized to be more drug-tolerant than routinely culturable bacilli. This hypothesis implies an alternative paradigm in which TB treatment does not rapidly reduce the total Mtb population but only the small, routinely culturable subpopulation. To evaluate these competing paradigms, we developed a culture-independent method for quantifying the viable fraction of Mtb bacilli in sputum during treatment. METHODS: We used GeneXpert MTB/RIF to quantify Mtb DNA in sputa collected longitudinally from Ugandan adults taking standard 4-drug treatment for drug-susceptible pulmonary TB. We modeled GeneXpert cycle thresholds over time using nonlinear mixed-effects regression. We adjusted these models for clearance of DNA from killed-but-not-yet-degraded bacilli, assuming clearance half-lives ranging from 0 to 1.25 days. We used a convolution integral to quantify DNA from viable bacilli only, and converted cycle thresholds to Mtb genomic equivalents. We replicated our results in a South African cohort. RESULTS: We enrolled 41 TB patients in Uganda. Assuming a DNA-clearance half-life of 0 days, genomic equivalents of viable sputum bacilli decreased by 0.22 log/day until 8.8 days, then by 0.07 log/day afterwards. Assuming a DNA-clearance half-life of 1.25 days, genomic equivalents of viable bacilli decreased by 0.36 log/day until 5.0 days, then by 0.06 log/day afterwards. By day 7, viable Mtb had decreased by 97.2-98.8%. We found similar results for 19 TB patients in South Africa. DISCUSSION: Using a culture-independent method, we found that TB treatment rapidly eliminates most viable Mtb in sputum. These findings are incompatible with the hypothesis that differentially culturable bacilli are drug-tolerant. CONCLUSIONS: A culture-independent method for measuring viable Mtb in sputum during treatment corroborates the traditional TB treatment paradigm in which a rapid bactericidal phase precedes slow, elimination of a small, residual bacillary subpopulation.
28 schema:genre research_article
29 schema:inLanguage en
30 schema:isAccessibleForFree true
31 schema:isPartOf N5984734d6a584df1bdbd024934edca61
32 N7470593c12ca4980a8dfea65e6e4f7d7
33 sg:journal.1024946
34 schema:name Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum
35 schema:pagination 293
36 schema:productId N44cb4fca71b743deaedcd4a61b33a76f
37 N4af38f09809d45b78794caf6593829e2
38 N4d113ae78482487fb2b8a66606b0edef
39 N4d9d3d4eb0e84b4a9de36093d7e22b53
40 Ndcbd4292ad7a47878018ccad9b703636
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105294105
42 https://doi.org/10.1186/s12879-018-3213-7
43 schema:sdDatePublished 2019-04-11T13:18
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher N0496e0d06c074dd7af43550519cc52b7
46 schema:url https://link.springer.com/10.1186%2Fs12879-018-3213-7
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N0496e0d06c074dd7af43550519cc52b7 schema:name Springer Nature - SN SciGraph project
51 rdf:type schema:Organization
52 N0a95d4ac8de64dcd95fff2d526874cd2 rdf:first sg:person.0706702615.44
53 rdf:rest Nfb0b2282e21e41a793e5387fdb11d0a9
54 N2aabc827235e4cdc9772aa57a9a7749a schema:name Department of Medicine, Mulago Hospital, Makerere University, Kampala, Uganda
55 Infectious Disease Research Collaboration, Kampala, Uganda
56 rdf:type schema:Organization
57 N31a9d2bd8bf94acfb4a5f472dbca6b9d rdf:first sg:person.010043724025.15
58 rdf:rest Ne2f153b3d35e4911adfa000a3672514c
59 N37136cdb8a784d728bf03847d6e3a526 rdf:first sg:person.010564201417.58
60 rdf:rest rdf:nil
61 N44cb4fca71b743deaedcd4a61b33a76f schema:name dimensions_id
62 schema:value pub.1105294105
63 rdf:type schema:PropertyValue
64 N4af38f09809d45b78794caf6593829e2 schema:name pubmed_id
65 schema:value 29970012
66 rdf:type schema:PropertyValue
67 N4d113ae78482487fb2b8a66606b0edef schema:name readcube_id
68 schema:value 69630b2fd4a031d4629e7bd79097f6053a54b71832abaaaa1dfa6c71bb22ba04
69 rdf:type schema:PropertyValue
70 N4d9d3d4eb0e84b4a9de36093d7e22b53 schema:name doi
71 schema:value 10.1186/s12879-018-3213-7
72 rdf:type schema:PropertyValue
73 N5984734d6a584df1bdbd024934edca61 schema:volumeNumber 18
74 rdf:type schema:PublicationVolume
75 N6a621c4a67db4185a56913d0f8da1867 rdf:first sg:person.01072660333.31
76 rdf:rest N31a9d2bd8bf94acfb4a5f472dbca6b9d
77 N7470593c12ca4980a8dfea65e6e4f7d7 schema:issueNumber 1
78 rdf:type schema:PublicationIssue
79 N9b4e35301f604a2b8ca8bcd8ec5921f7 rdf:first sg:person.014310416353.38
80 rdf:rest Nb4037776f97f4c1f92be9a069890992b
81 Na5026ff5de354afea02d79b74c065366 schema:affiliation https://www.grid.ac/institutes/grid.168010.e
82 schema:familyName Schoolnik
83 schema:givenName Gary S.
84 rdf:type schema:Person
85 Nb4037776f97f4c1f92be9a069890992b rdf:first sg:person.01135416527.61
86 rdf:rest Nfc2cee82f6fd43c68a22c06bef6e672b
87 Nc682ef0dfee94513b133c199b7f142d4 rdf:first sg:person.0711160455.90
88 rdf:rest N37136cdb8a784d728bf03847d6e3a526
89 Ndcbd4292ad7a47878018ccad9b703636 schema:name nlm_unique_id
90 schema:value 100968551
91 rdf:type schema:PropertyValue
92 Ne2f153b3d35e4911adfa000a3672514c rdf:first sg:person.01130221352.89
93 rdf:rest N9b4e35301f604a2b8ca8bcd8ec5921f7
94 Nfb0b2282e21e41a793e5387fdb11d0a9 rdf:first Na5026ff5de354afea02d79b74c065366
95 rdf:rest Nc682ef0dfee94513b133c199b7f142d4
96 Nfc2cee82f6fd43c68a22c06bef6e672b rdf:first sg:person.012465155177.41
97 rdf:rest N0a95d4ac8de64dcd95fff2d526874cd2
98 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
99 schema:name Medical and Health Sciences
100 rdf:type schema:DefinedTerm
101 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
102 schema:name Pharmacology and Pharmaceutical Sciences
103 rdf:type schema:DefinedTerm
104 sg:grant.2418123 http://pending.schema.org/fundedItem sg:pub.10.1186/s12879-018-3213-7
105 rdf:type schema:MonetaryGrant
106 sg:grant.2421217 http://pending.schema.org/fundedItem sg:pub.10.1186/s12879-018-3213-7
107 rdf:type schema:MonetaryGrant
108 sg:grant.2541757 http://pending.schema.org/fundedItem sg:pub.10.1186/s12879-018-3213-7
109 rdf:type schema:MonetaryGrant
110 sg:grant.3535187 http://pending.schema.org/fundedItem sg:pub.10.1186/s12879-018-3213-7
111 rdf:type schema:MonetaryGrant
112 sg:grant.4102552 http://pending.schema.org/fundedItem sg:pub.10.1186/s12879-018-3213-7
113 rdf:type schema:MonetaryGrant
114 sg:grant.5475983 http://pending.schema.org/fundedItem sg:pub.10.1186/s12879-018-3213-7
115 rdf:type schema:MonetaryGrant
116 sg:journal.1024946 schema:issn 1471-2334
117 schema:name BMC Infectious Diseases
118 rdf:type schema:Periodical
119 sg:person.010043724025.15 schema:affiliation https://www.grid.ac/institutes/grid.240341.0
120 schema:familyName Moore
121 schema:givenName Camille M.
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010043724025.15
123 rdf:type schema:Person
124 sg:person.010564201417.58 schema:affiliation https://www.grid.ac/institutes/grid.47100.32
125 schema:familyName Davis
126 schema:givenName J. Lucian
127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010564201417.58
128 rdf:type schema:Person
129 sg:person.01072660333.31 schema:affiliation https://www.grid.ac/institutes/grid.430503.1
130 schema:familyName Walter
131 schema:givenName Nicholas D.
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072660333.31
133 rdf:type schema:Person
134 sg:person.01130221352.89 schema:affiliation https://www.grid.ac/institutes/grid.430503.1
135 schema:familyName Kayigire
136 schema:givenName Xavier A.
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130221352.89
138 rdf:type schema:Person
139 sg:person.01135416527.61 schema:affiliation N2aabc827235e4cdc9772aa57a9a7749a
140 schema:familyName Worodria
141 schema:givenName William
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135416527.61
143 rdf:type schema:Person
144 sg:person.012465155177.41 schema:affiliation https://www.grid.ac/institutes/grid.266102.1
145 schema:familyName Huang
146 schema:givenName Laurence
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012465155177.41
148 rdf:type schema:Person
149 sg:person.014310416353.38 schema:affiliation https://www.grid.ac/institutes/grid.414594.9
150 schema:familyName Dide-Agossou
151 schema:givenName Christian
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014310416353.38
153 rdf:type schema:Person
154 sg:person.0706702615.44 schema:affiliation https://www.grid.ac/institutes/grid.266102.1
155 schema:familyName Everett
156 schema:givenName Charles K.
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706702615.44
158 rdf:type schema:Person
159 sg:person.0711160455.90 schema:affiliation https://www.grid.ac/institutes/grid.266102.1
160 schema:familyName Nahid
161 schema:givenName Payam
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711160455.90
163 rdf:type schema:Person
164 sg:pub.10.1038/nrmicro3076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024379299
165 https://doi.org/10.1038/nrmicro3076
166 rdf:type schema:CreativeWork
167 sg:pub.10.1186/s12879-016-1696-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029636369
168 https://doi.org/10.1186/s12879-016-1696-7
169 rdf:type schema:CreativeWork
170 sg:pub.10.1186/s12916-016-0609-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027451381
171 https://doi.org/10.1186/s12916-016-0609-3
172 rdf:type schema:CreativeWork
173 https://app.dimensions.ai/details/publication/pub.1083123026 schema:CreativeWork
174 https://doi.org/10.1016/j.tube.2010.03.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041902759
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/j.tube.2016.08.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034869919
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1046/j.1365-2958.2002.02779.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1017319679
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1073/pnas.1705385114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085731090
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1093/cid/civ1223 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059467409
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1093/infdis/jiv149 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042306309
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1093/jac/dkt357 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012231163
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1093/jac/dku415 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047592023
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1128/aac.00774-05 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052810980
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1128/aac.01380-15 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000191663
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1128/jcm.00128-10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040312811
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1164/ajrccm.160.1.9811006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003405776
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1164/rccm.200210-1125oc schema:sameAs https://app.dimensions.ai/details/publication/pub.1041796096
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1164/rccm.201604-0769oc schema:sameAs https://app.dimensions.ai/details/publication/pub.1029247559
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1164/rccm.201607-1431ed schema:sameAs https://app.dimensions.ai/details/publication/pub.1023909116
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1371/journal.pmed.0040120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037046441
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1378/chest.76.6_supplement.771 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026581588
207 rdf:type schema:CreativeWork
208 https://www.grid.ac/institutes/grid.168010.e schema:alternateName Stanford University
209 schema:name Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA
210 rdf:type schema:Organization
211 https://www.grid.ac/institutes/grid.240341.0 schema:alternateName National Jewish Health
212 schema:name Division of Biostatistics and Bioinformatics, National Jewish Health, Denver, CO, USA
213 rdf:type schema:Organization
214 https://www.grid.ac/institutes/grid.266102.1 schema:alternateName University of California, San Francisco
215 schema:name Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
216 HIV, Infectious Diseases, and Global Medicine Division, San Francisco General Hospital, University of California San Francisco, San Francisco, CA, USA
217 Pulmonary Associates, Burlingame, CA, USA
218 rdf:type schema:Organization
219 https://www.grid.ac/institutes/grid.414594.9 schema:alternateName Colorado School of Public Health
220 schema:name Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA
221 rdf:type schema:Organization
222 https://www.grid.ac/institutes/grid.430503.1 schema:alternateName University of Colorado Anschutz Medical Campus
223 schema:name Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO, USA
224 Pulmonary Section, Denver VA Medical Center, Denver, CO, USA
225 rdf:type schema:Organization
226 https://www.grid.ac/institutes/grid.47100.32 schema:alternateName Yale University
227 schema:name Division of Pulmonary, Critical Care, and Sleep Medicine Section, Yale School of Medicine, New Haven, CT, USA
228 Yale School of Public Health, New Haven, CT, USA
229 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...